Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways

Life Sci. 2020 Sep 15:257:118044. doi: 10.1016/j.lfs.2020.118044. Epub 2020 Jul 2.

Abstract

Aims: High-dose glucocorticoid (GC) administration causes osteoporosis. Many previous studies from our group and other groups have shown that melatonin participates in the regulation of osteoblast proliferation and differentiation, especially low concentrations of melatonin, which enhance osteoblast osteogenesis. However, the role of melatonin in glucocorticoid-induced osteoblast differentiation remains unknown.

Materials and methods: An examination of the expression of osteoblast differentiation markers (ALP, OCN, COLL-1), as well as alkaline phosphatase staining and alkaline phosphatase enzymatic activity assay to measure osteoblast differentiation and quantifying Alizarin red S staining to measure mineralization, were performed to determine the effects of dexamethasone (Dex) and melatonin on the differentiation of MC3T3-E1 cells. We used immunofluorescence staining to detect the expression of Runx2 in melatonin-treated MC3T3-E1 cells. The expression of mRNA was determined by qRT-PCR, and protein levels were measured by western blotting.

Key findings: In the present study, we found that 100 μM Dex significantly reduced osteoblast differentiation and mineralization in MC3T3-E1 cells and that 1 μM melatonin attenuated these inhibitory effects. We found that only inhibition of PI3K/AKT (MK2206) and BMP/Smad (LDN193189) signalling abolished melatonin-induced differentiation and mineralization. Meanwhile, MK2206 decreased the expression of P-AKT and P-Smad1/5/9 and LDN193189 decreased the expression of P-Smad1/5/9 but had no obvious effect on P-AKT expression in melatonin-treated and Dex-induced MC3T3-E1 cells.

Significance: These findings suggest that melatonin rescues Dex-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways and that PI3K/AKT signalling may be the upstream signal of BMP/Smad signalling.

Keywords: BMP/Smad signalling; Glucocorticoid; Melatonin; Osteoblast differentiation; PI3K/AKT signalling.

MeSH terms

  • Animals
  • Biomineralization / drug effects
  • Bone Morphogenetic Protein 2 / metabolism
  • Bone Morphogenetic Proteins / metabolism
  • Calcification, Physiologic / drug effects
  • Cell Differentiation / drug effects*
  • Cell Line
  • Dexamethasone / pharmacology
  • Gene Expression Regulation / drug effects
  • Glucocorticoids / adverse effects
  • Glucocorticoids / pharmacology
  • Melatonin / metabolism*
  • Melatonin / pharmacology
  • Mice
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism*
  • Osteogenesis / drug effects
  • Phosphatidylinositol 3-Kinases / metabolism
  • Proto-Oncogene Proteins c-akt / metabolism
  • Signal Transduction / drug effects
  • Smad Proteins / metabolism

Substances

  • Bone Morphogenetic Protein 2
  • Bone Morphogenetic Proteins
  • Glucocorticoids
  • Smad Proteins
  • Dexamethasone
  • Proto-Oncogene Proteins c-akt
  • Melatonin